Summary
This 8-K filing from Pfizer Inc. (PFE) on November 5, 2020, primarily serves to announce details regarding the upcoming 'when-issued' trading of Viatris Inc. common stock and 'ex-distribution' trading of Pfizer common stock. This relates to the previously announced spin-off of Pfizer's Upjohn Business and its subsequent combination with Mylan N.V. to form Viatris. Investors should pay attention to these trading mechanics as they signal the imminent completion of this significant strategic transaction.
Key Highlights
- 1Announcement of 'when-issued' trading for Viatris Inc. common stock.
- 2Announcement of 'ex-distribution' trading for Pfizer Inc. common stock.
- 3Details provided in connection with the spin-off of Pfizer's Upjohn Business.
- 4Information relates to the proposed combination of the Upjohn Business with Mylan N.V. to form Viatris.
- 5The press release attached as Exhibit 99.1 contains the specific details of these trading arrangements.
- 6This filing indicates the transaction is progressing towards completion.